Business · Vietnam Bureau
VNVC and Pfizer deepen partnership to boost Vietnam vaccine production
Vietnam's leading vaccine distributor VNVC is expanding its collaboration with Pfizer to accelerate domestic vaccine manufacturing capabilities. The partnership will explore production of advanced vaccines as Vietnam strengthens its immunization infrastructure.
LSN Vietnam ·
VNVC and Pfizer have committed to broadening their cooperation in vaccination and disease prevention initiatives, marking a significant step in Vietnam's efforts to develop indigenous vaccine manufacturing capacity.
The expanded partnership will focus on assessing production feasibility for next-generation vaccines, potentially reducing Vietnam's reliance on imported immunological products. The collaboration aligns with Vietnam's broader healthcare modernization strategy and aims to enhance the country's preparedness against infectious diseases.
As a major pharmaceutical distributor, VNVC plays a critical role in Vietnam's vaccination ecosystem. The company's engagement with Pfizer underscores growing interest among international vaccine manufacturers in supporting local production capabilities across Southeast Asia.
The initiative comes as Vietnam continues investing in healthcare infrastructure and pharmaceutical self-sufficiency. By developing domestic manufacturing expertise, the country aims to improve vaccine accessibility while creating skilled employment opportunities in the life sciences sector.
Details regarding investment commitments, timeline, and specific vaccine candidates under consideration have not been disclosed. Industry analysts expect further announcements as the cooperation progresses through feasibility assessment phases.